Acelyrin Inc (DELISTED) (SLRN:DL)
2.27
0.00 (0.00%)
USD |
NASDAQ |
May 23, 16:00
Acelyrin Shareholders Equity (Quarterly) : 407.23M for March 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alumis, Inc. | 384.77M |
| OptiNose Inc (DELISTED) | -61.37M |
| Akoya Biosciences Inc (DELISTED) | -5.889M |
| Sutro Biopharma, Inc. | -87.27M |
| Pliant Therapeutics, Inc. | 200.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 436.50M |
| Total Liabilities (Quarterly) | 29.27M |